JP2007529503A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529503A5
JP2007529503A5 JP2007503444A JP2007503444A JP2007529503A5 JP 2007529503 A5 JP2007529503 A5 JP 2007529503A5 JP 2007503444 A JP2007503444 A JP 2007503444A JP 2007503444 A JP2007503444 A JP 2007503444A JP 2007529503 A5 JP2007529503 A5 JP 2007529503A5
Authority
JP
Japan
Prior art keywords
hib
vaccine
antigen
conjugate
protect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007503444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529503A (ja
JP4954056B2 (ja
Filing date
Publication date
Priority claimed from GBGB0405787.3A external-priority patent/GB0405787D0/en
Application filed filed Critical
Publication of JP2007529503A publication Critical patent/JP2007529503A/ja
Publication of JP2007529503A5 publication Critical patent/JP2007529503A5/ja
Application granted granted Critical
Publication of JP4954056B2 publication Critical patent/JP4954056B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007503444A 2004-03-15 2005-03-14 低用量のHib結合体との組合せワクチン Expired - Fee Related JP4954056B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0405787.3 2004-03-15
GBGB0405787.3A GB0405787D0 (en) 2004-03-15 2004-03-15 Low dose vaccines
PCT/IB2005/000927 WO2005089794A2 (en) 2004-03-15 2005-03-14 Combination vaccines with low dose of hib conjugate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008056997A Division JP2008150397A (ja) 2004-03-15 2008-03-06 低用量のHib結合体との組合せワクチン

Publications (3)

Publication Number Publication Date
JP2007529503A JP2007529503A (ja) 2007-10-25
JP2007529503A5 true JP2007529503A5 (https=) 2008-04-24
JP4954056B2 JP4954056B2 (ja) 2012-06-13

Family

ID=32117706

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007503444A Expired - Fee Related JP4954056B2 (ja) 2004-03-15 2005-03-14 低用量のHib結合体との組合せワクチン
JP2008056997A Pending JP2008150397A (ja) 2004-03-15 2008-03-06 低用量のHib結合体との組合せワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008056997A Pending JP2008150397A (ja) 2004-03-15 2008-03-06 低用量のHib結合体との組合せワクチン

Country Status (13)

Country Link
US (2) US20090208526A1 (https=)
EP (1) EP1725258B1 (https=)
JP (2) JP4954056B2 (https=)
CN (2) CN102028944B (https=)
AT (1) ATE480257T1 (https=)
BR (1) BRPI0508813B8 (https=)
CA (1) CA2559996C (https=)
DE (1) DE602005023422D1 (https=)
DK (1) DK1725258T3 (https=)
GB (1) GB0405787D0 (https=)
RU (1) RU2435609C2 (https=)
SG (1) SG151253A1 (https=)
WO (1) WO2005089794A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20024224A3 (cs) * 2000-06-29 2003-05-14 Glaxosmithkline Biologicals S. A. Farmaceutický prostředek
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
PE20110072A1 (es) 2005-06-27 2011-02-04 Glaxosmithkline Biolog Sa Composicion inmunogenica
JP5814507B2 (ja) 2006-09-07 2015-11-17 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0700135D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Vaccine
ES2555786T3 (es) * 2007-06-04 2016-01-08 Glaxosmithkline Biologicals Sa Formulación de vacunas contra la meningitis
CU23652A1 (es) * 2007-06-29 2011-05-27 Centro Inmunologia Molecular Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención
CN102066401A (zh) 2008-05-01 2011-05-18 艾瑞克有限公司 蛋白质制品
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
PE20100366A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
WO2011027222A2 (en) 2009-09-02 2011-03-10 Novartis Ag Immunogenic compositions including tlr activity modulators
CN102655879B (zh) * 2009-12-16 2016-03-09 印度血清研究所 疫苗组合物
AU2011295853A1 (en) 2010-09-01 2013-04-04 Irm Llc Adsorption of immunopotentiators to insoluble metal salts
WO2012117377A1 (en) * 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
BR112013027057A2 (pt) 2011-04-21 2020-08-11 Trustees Of Tufts College composições e métodos para a estabilização de agentes ativos
MX372965B (es) 2012-03-08 2020-04-01 Glaxosmithkline Biologicals Sa Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
US20150297714A1 (en) * 2012-10-29 2015-10-22 The Board Of Trustees Of The University Of Arkansas Novel mucosal adjuvants and delivery systems
RU2626532C2 (ru) * 2015-01-16 2017-07-28 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в
US11027005B2 (en) * 2016-10-20 2021-06-08 Km Biologics Co., Ltd. Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
CN111032078A (zh) 2017-07-18 2020-04-17 血清研究所印度私人有限公司 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
EA202190778A1 (ru) 2018-10-12 2021-08-05 Серум Инститьют Оф Индия Прайват Лтд Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition
CN118903397A (zh) * 2024-10-12 2024-11-08 成都迈科康生物科技有限公司 GloboH六糖、linker化合物、蛋白偶联物及免疫原性组合物在治疗或抑制上皮性肿瘤中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734484B1 (fr) * 1995-05-24 1997-06-27 Pasteur Merieux Serums Vacc Composition vaccinale liquide et procede de fabrication
PL184872B1 (pl) * 1995-06-23 2003-01-31 Smithkline Beecham Biolog Kombinowana szczepionkaĆ zestaw do przygotowania kombinowanej szczepionkiĆ sposób wytwarzania kombinowanej szczepionki i jej zastosowanie
US20020054884A1 (en) * 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
CZ20024224A3 (cs) 2000-06-29 2003-05-14 Glaxosmithkline Biologicals S. A. Farmaceutický prostředek

Similar Documents

Publication Publication Date Title
JP2007529503A5 (https=)
RU2006136212A (ru) КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЬЮГАТА Hib
CA1256250A (en) Covalently-modified neutral bacterial poly- saccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
RU2012116119A (ru) Множественная вакцинация, включающая менингококки серогруппы с
JP2010516763A5 (https=)
JP2012506421A5 (https=)
JP2015034178A (ja) 全細胞百日咳抗原を含む混合ワクチン
JP2011500662A5 (https=)
JP2007507578A5 (https=)
JP2008525423A5 (https=)
JP2004536859A5 (https=)
CN107427568A (zh) 用于肺炎球菌疫苗中的免疫原性组合物
RU2007127993A (ru) Сахарид-конъюгатные вакцины
HU227893B1 (en) Vaccine compositions
MXPA05004675A (es) Proceso de secado.
JP2009227680A5 (https=)
JP2012506421A (ja) 新規な無細胞百日咳ワクチン組成物およびその製造方法
RU2006114677A (ru) Жидкие вакцины для множественных серогрупп менингококков
JP2010500398A5 (https=)
RU2504398C2 (ru) Комбинированная вакцина с цельноклеточным коклюшем
CN104487086A (zh) 无动物源的不含酒精的疫苗组合物及其制备方法
JP2011504535A5 (https=)
US10060928B2 (en) Method for determining the endotoxin content of an aluminum salt preparation
CA3105361A1 (en) Improvements in immunogenic conjugates
TWI880080B (zh) 六合一液狀疫苗組成物